1 change Rule, last 7 days

FDA Approves Tec-Dara for Relapsed Multiple Myeloma

The FDA has approved Tec-Dara (teclistamab and daratumumab hyaluronidase-fihj) for relapsed or refractory multiple myeloma. This approval was granted under the Commissioner's National Priority Voucher (CNPV) pilot program, marking a significant acceleration in the review process.

Priority review Rule Healthcare

Get alerts for ""

We'll email you when new changes match this search.

Free. Unsubscribe anytime.